Profile of specific antibodies to the SARS-associated coronavirus [6]

New England Journal of Medicine

Volumn 349, Issue 5, 2003, Pages 508-509

  Li, Gang ^a   Chen, Xuejuan ^a   Xu, Anlong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; CORONAVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; LETTER; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS PNEUMONIA; IMMUNOLOGY; METABOLISM; SARS CORONAVIRUS;

HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0042343795     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200307313490520     Document Type: Letter

References (4)

1. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
2. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
3. Poutanen SM, Low DE, Henry B, et al. Identification ofsevere acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
4. Kawai H, Feinstone SM. Acute viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Vol. 1. Philadelphia: Churchill Livingstone, 2000:1279-97.